British Columbia source: bounded use
Anaphylaxis: Diagnosis and Treatment supplies a Canadian implementation example for this summary. It must not be presented as the rule outside British Columbia.
sources for this section:ECBC anaphylaxis
Source-attributed clinical priorities
- Recognize anaphylaxis clinically when acute airway, breathing or circulation compromise or multisystem features follow a likely trigger.
- Give intramuscular epinephrine promptly and repeat according to response while positioning, oxygen, fluids and airway support are arranged.
- Observe according to severity and risk, prescribe and teach an autoinjector when indicated, and arrange trigger and allergy follow-up.
- Intramuscular epinephrine is first-line; antihistamines do not treat airway obstruction or shock.
sources for this section:ECBC anaphylaxis
Practical assessment and management workflow
1
Recognize rapid airway, breathing or circulation compromise or multisystem allergic symptoms after exposure.
2
Give epinephrine into the lateral thigh and repeat according to response while calling emergency support.
3
Position safely, provide oxygen and fluid resuscitation and monitor for recurrence.
4
Before discharge, prescribe and teach an autoinjector when indicated and arrange allergy referral and an action plan.
sources for this section:ECBC anaphylaxis
Safety, red flags and urgent escalation
- Do not delay epinephrine for IV access, antihistamine or corticosteroid.
- Refractory shock or airway edema requires advanced resuscitation and critical-care expertise.
- Avoid suddenly standing or walking a hypotensive patient because cardiovascular collapse can worsen.
sources for this section:ECBC anaphylaxis
Confirm the local pathway before acting
British Columbia is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient鈥檚 province or territory.
sources for this section:ECBC anaphylaxis
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:ECBC anaphylaxis
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Emergency Care BCAnaphylaxis: Diagnosis and Treatmentaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.